We offer several fellowship opportunities each year. Please review the opportunities below for our specific rotations and additional information regarding the program.
Combined Harvard Pediatric Multiple Sclerosis and Neuroimmunology Fellowship
- Directors: Tanuja Chitnis, MD & Mark Gorman, MD
- Fellows rotate through the pediatric MS and neuroimmunology clinics at Massachusetts General Hospital (with Dr. Chitnis) and at Boston Children’s Hospital (with Dr. Gorman), and adult MS clinic at Brigham and Women’s Hospital (with Dr. Chitnis).
- Fellows will learn about pediatric MS, NMO and related demyelinating disorders (DD) and will build a knowledge base regarding MS, NMO and DD clinical care.
- For additional information regarding this fellowship, please visit our pediatric site.
We are currently accepting applications for academic year 2022 (July 2021 – June 2022). Applications are due by February 1, 2020.
A complete application consists of (1) your CV, (2) a personal statement, and (3) two letters of recommendation. Letters of recommendation must be sent directly from your referee to firstname.lastname@example.org by the application deadline.
Postdoctoral Research Fellowship, Translational Neuroimmunology Research Center
- Director & PI: Tanuja Chitnis, MD
- Fellows participate in clinical research projects focused on clinical, biomarker and MRI features of MS using data from the CLIMB Study.
We are currently not accepting applications for this opportunity. Please check back for future openings.
Multiple Sclerosis Clinical Fellowship
- Directors: Tanuja Chitnis, MD & James Stankiewicz, MD
- Fellows rotate through the Partners MS Center at the Brigham and Women’s Hospital for 1-2 years in preparation for a career as a MS specialist.
- Training is comprised of direct supervised MS patient care, exposure to multidisciplinary care, and didactic activities.
- The program is funded by Biogen Idec, Tiziana Life Sciences, and the National MS Society (AY20). Individual fellowship funding opportunities may be applied for.
- This program is internally reviewed by the Partners Education Committee and administered by Partners Graduate Medical Education (GME).
- Eligible applicants will have successfully completed a residency training program in the US or Canada. Please reference the institutional policy surrounding USMLE completion for clinical trainees.
At this time, we are not accepting applications for AY22 (July 2021 – June 2022). We will open the submission cycle for AY23 in the summer of 2020, please check back for updates.